UROGEN PHARMA LTD (URGN) insider trading activity (SEC Form 4). Over the trailing 90 days, URGN insiders filed 0 purchases totalling $0 and 4 sales totalling $1.2M — net SELLING of $1.2M. Most recent filing: Jul 10, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Jul 10, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | — | $40.00 | $400K | filing |
| Jun 24, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | — | $35.01 | $350K | filing |
| Jun 9, 2026 | Schoenberg Mark | Chief Medical Officer | S SaleOE | — | $27.30 | $143K | filing |
| May 11, 2026 | Schoenberg Mark | Chief Medical Officer | S Sale | — | $30.00 | $300K | filing |